Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.

Mbunwe E, Van der Auwera BJ, Weets I, Van Crombrugge P, Crenier L, Coeckelberghs M, Seret N, Decochez K, Vandemeulebroucke E, Gillard P, Keymeulen B, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry..

Diabetologia. 2013 Sep;56(9):1964-70. doi: 10.1007/s00125-013-2951-8.

2.

HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Mbunwe E, Van der Auwera BJ, Vermeulen I, Demeester S, Van Dalem A, Balti EV, Van Aken S, Derdelinckx L, Dorchy H, De Schepper J, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers D, Weets I, Gorus FK; Belgian Diabetes Registry..

Diabetes. 2013 Apr;62(4):1345-50. doi: 10.2337/db12-0747.

3.

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators..

Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x.

PMID:
21388447
4.

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Vandemeulebroucke E, Keymeulen B, Decochez K, Weets I, De Block C, Féry F, Van de Velde U, Vermeulen I, De Pauw P, Mathieu C, Pipeleers DG, Gorus FK; Belgian Diabetes Registry..

Diabetologia. 2010 Jan;53(1):36-44. doi: 10.1007/s00125-009-1569-3.

PMID:
19898832
5.

[Guidelines on cardiovascular disease prevention in clinical practice. Belgian Working Group on Cardiovascular Prevention and Rehabilitation].

Dereppe H, Laruelle C, De Backer G, Brohet C, Daubresse JC, Dendale P, Fagardy R, Legat P, De Sutter J; Belgian Working Group on Cardiovascular Prevention and Rehabilitation..

Rev Med Brux. 2009 Jan-Feb;30(1):37-46. French.

PMID:
19353941
6.

Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia.

Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G; Discovery Belux..

Acta Cardiol. 2008 Aug;63(4):493-9.

7.

[Inhaled human insulin (Exubera): a revolution?].

Daubresse JC, Sternon J.

Rev Med Brux. 2006 Nov-Dec;27(6):493-7. French.

PMID:
17256415
8.

[Omega-3 fatty acids and cardiovascular diseases].

Daubresse JC, Sternon J.

Rev Med Brux. 2006 Jan-Feb;27(1):43-8. Review. French.

PMID:
16608011
9.

[Hospital in-patients with diabetes].

Daubresse C, Daubresse JC.

Rev Med Liege. 2005 May-Jun;60(5-6):594-8. Review. French.

PMID:
16035334
10.

[Treatment of type 2 diabetes].

Daubresse JC.

Rev Med Brux. 2004 Feb;25(1):22-8. Review. French.

PMID:
15053151
11.

The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man.

Marion E, Kaisaki PJ, Pouillon V, Gueydan C, Levy JC, Bodson A, Krzentowski G, Daubresse JC, Mockel J, Behrends J, Servais G, Szpirer C, Kruys V, Gauguier D, Schurmans S.

Diabetes. 2002 Jul;51(7):2012-7.

12.

Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood.

Weets I, Siraux V, Daubresse JC, De Leeuw IH, Féry F, Keymeulen B, Krzentowski G, Letiexhe M, Mathieu C, Nobels F, Rottiers R, Scheen A, Van Gaal L, Schuit FC, Van der Auwera B, Rui M, De Pauw P, Kaufman L, Gorus FK; Belgian Diabetes Registry..

J Clin Endocrinol Metab. 2002 Jun;87(6):2597-605.

PMID:
12050221
13.

The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation.

Weets I, De Leeuw IH, Du Caju MV, Rooman R, Keymeulen B, Mathieu C, Rottiers R, Daubresse JC, Rocour-Brumioul D, Pipeleers DG, Gorus FK; Belgian Diabetes Registry..

Diabetes Care. 2002 May;25(5):840-6.

PMID:
11978678
14.

[Type 2 diabetes: a refractory pathology?].

Daubresse JC.

Rev Med Brux. 2001 Jun;22(3):A184-6. French. No abstract available.

PMID:
11488089
15.

[The importance of syndrome X in daily practice].

Daubresse JC.

Rev Med Brux. 2000 Dec;21(6):473-7. Review. French.

PMID:
11194491
16.

[Atherosclerosis and nutrition].

Daubresse JC.

Rev Med Brux. 2000 Sep;21(4):A359-62. French.

PMID:
11068494
17.

Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study.

Daubresse JC, Kolanowski J, Krzentowski G, Kutnowski M, Scheen A, Van Gaal L.

Obes Res. 1996 Jul;4(4):391-6.

18.
19.

Guidelines for diagnosis and treatment of adult hyperlipidaemias. Consensus of the Belgian Lipid Club.

Ducobu J, Daubresse JC.

Acta Clin Belg. 1994;49(5):243-8. Review. No abstract available.

PMID:
7992570
20.

[Hyperlipidemia and atherosclerosis: epidemiology, biochemistry and therapy].

Ducobu J, Berghmans L, Carpentier YA, Daubresse JC, Kornitzer M, Balasse E.

Rev Med Brux. 1993 Oct;14(8):239-45. French.

PMID:
8272680
Items per page

Supplemental Content

Loading ...
Support Center